AstraZeneca announces new deals with biotechs

02/1/2007 | Bloomberg · Reuters

AstraZeneca said it will acquire U.K. biotech company Arrow Therapeutics for $150 million to boost research on bacteria and virus compounds, a day after announcing two licensing agreements worth $800 million to develop obesity and respiratory drugs. The drugmaker also announced plans to cut 3,000 jobs.

View Full Article in:

Bloomberg · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN